Washington Post National Health Reporter Paige Winfield Cunningham discusses how the Trump administration is considering ...

According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program ...

Thousands of Rhode Island seniors and disabled residents no longer covered for non-emergency visits at four local hospitals ...

A new study reveals that Medicare beneficiaries are receiving billions of dollars worth of medical care that offer little to no clinical benefit and may lead to harm. Researchers found that Medicare ...

Some obese Americans on Medicare and Medicaid could get access to expensive weight loss drugs under a five-year experiment ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

A new rule issued by the Centers for Medicare and Medicaid Services will strip DACA recipients of eligibility for coverage ...

DHS' Temporary Commissioner Shireen Gandhi wrote a letter Friday to the federal Centers for Medicare and Medicaid Services ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

The Centers for Medicare & Medicaid Services Aug. 1 issued a final rule for the inpatient psychiatric facility prospective ...